 | • レポートコード：QY2112C03744 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療装置 |
| Single User | ￥686,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,029,000 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,372,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は関節リウマチ用デバイスの世界市場の現状について調査・分析し、2027年までの市場を予測しました。関節リウマチ用デバイスの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（埋め込み型関節プロテーゼ、脊椎デバイス、その他）、用途別市場規模（高齢者、若年層）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・関節リウマチ用デバイスの世界市場概要 ・メーカー別の競争状況、市場シェア ・関節リウマチ用デバイスの種類別市場規模：埋め込み型関節プロテーゼ、脊椎デバイス、その他 ・関節リウマチ用デバイスの用途別市場規模：高齢者、若年層 ・北米の関節リウマチ用デバイス市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの関節リウマチ用デバイス市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの関節リウマチ用デバイス市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の関節リウマチ用デバイス市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの関節リウマチ用デバイス市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Active Implants LLC、Anika Therapeutics, Inc.、Arthrex, Inc.、Asahi Kasei Pharma Corporation、B. Braun Melsungen AG、CONMED Corporation、EMulate Therapeutics, Inc. (Nativis, Inc.)、Integra Lifesciences Corporation、Johnson & Johnson (DePuy Synthes Inc.)、Novartis AG、RTI Surgical, Inc.、Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)、Setpoint Medical Corporation、Smith & Nephew plc (Osiris Therapeutics, Inc.)、Stryker Corporation (OrthoSpace Ltd.)、UCB Pharma S.A.、Zimmer Biomet ・関節リウマチ用デバイスのバリューチェーン・販売チャネル分析 ・関節リウマチ用デバイスの世界市場動向 |
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.
Market Analysis and Insights: Global Rheumatoid Arthritis Devices Market
The global Rheumatoid Arthritis Devices market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
Global Rheumatoid Arthritis Devices Scope and Segment
Rheumatoid Arthritis Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Implantable Joint Prostheses
Spinal Devices
Other
Segment by Application
Elderly
Young adults
By Company
Active Implants LLC
Anika Therapeutics, Inc.
Arthrex, Inc.
Asahi Kasei Pharma Corporation
B. Braun Melsungen AG
CONMED Corporation
EMulate Therapeutics, Inc. (Nativis, Inc.)
Integra Lifesciences Corporation
Johnson & Johnson (DePuy Synthes Inc.)
Novartis AG
RTI Surgical, Inc.
Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
Setpoint Medical Corporation
Smith & Nephew plc (Osiris Therapeutics, Inc.)
Stryker Corporation (OrthoSpace Ltd.)
UCB Pharma S.A.
Zimmer Biomet
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Rheumatoid Arthritis Devices Product Introduction
1.2 Market by Type
1.2.1 Global Rheumatoid Arthritis Devices Market Size Growth Rate by Type
1.2.2 Implantable Joint Prostheses
1.2.3 Spinal Devices
1.2.4 Other
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Devices Market Size Growth Rate by Application
1.3.2 Elderly
1.3.3 Young adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rheumatoid Arthritis Devices Sales Estimates and Forecasts 2016-2027
2.2 Global Rheumatoid Arthritis Devices Revenue Estimates and Forecasts 2016-2027
2.3 Global Rheumatoid Arthritis Devices Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Rheumatoid Arthritis Devices Regions by Sales
2.4.1 Global Top Rheumatoid Arthritis Devices Regions by Sales (2016-2021)
2.4.2 Global Top Rheumatoid Arthritis Devices Regions by Sales (2022-2027)
2.5 Global Top Rheumatoid Arthritis Devices Regions by Revenue
2.5.1 Global Top Rheumatoid Arthritis Devices Regions by Revenue (2016-2021)
2.5.2 Global Top Rheumatoid Arthritis Devices Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rheumatoid Arthritis Devices Sales by Manufacturers
3.1.1 Global Top Rheumatoid Arthritis Devices Manufacturers by Sales (2016-2021)
3.1.2 Global Top Rheumatoid Arthritis Devices Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Devices Sales in 2020
3.2 Global Rheumatoid Arthritis Devices Revenue by Manufacturers
3.2.1 Global Top Rheumatoid Arthritis Devices Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Rheumatoid Arthritis Devices Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Devices Revenue in 2020
3.3 Global Rheumatoid Arthritis Devices Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rheumatoid Arthritis Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rheumatoid Arthritis Devices Sales by Type
4.1.1 Global Rheumatoid Arthritis Devices Historical Sales by Type (2016-2021)
4.1.2 Global Rheumatoid Arthritis Devices Forecasted Sales by Type (2022-2027)
4.1.3 Global Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2027)
4.2 Global Rheumatoid Arthritis Devices Revenue by Type
4.2.1 Global Rheumatoid Arthritis Devices Historical Revenue by Type (2016-2021)
4.2.2 Global Rheumatoid Arthritis Devices Forecasted Revenue by Type (2022-2027)
4.2.3 Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2027)
4.3 Global Rheumatoid Arthritis Devices Price by Type
4.3.1 Global Rheumatoid Arthritis Devices Price by Type (2016-2021)
4.3.2 Global Rheumatoid Arthritis Devices Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Rheumatoid Arthritis Devices Sales by Application
5.1.1 Global Rheumatoid Arthritis Devices Historical Sales by Application (2016-2021)
5.1.2 Global Rheumatoid Arthritis Devices Forecasted Sales by Application (2022-2027)
5.1.3 Global Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2027)
5.2 Global Rheumatoid Arthritis Devices Revenue by Application
5.2.1 Global Rheumatoid Arthritis Devices Historical Revenue by Application (2016-2021)
5.2.2 Global Rheumatoid Arthritis Devices Forecasted Revenue by Application (2022-2027)
5.2.3 Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2016-2027)
5.3 Global Rheumatoid Arthritis Devices Price by Application
5.3.1 Global Rheumatoid Arthritis Devices Price by Application (2016-2021)
5.3.2 Global Rheumatoid Arthritis Devices Price Forecast by Application (2022-2027)
6 North America
6.1 North America Rheumatoid Arthritis Devices Market Size by Type
6.1.1 North America Rheumatoid Arthritis Devices Sales by Type (2016-2027)
6.1.2 North America Rheumatoid Arthritis Devices Revenue by Type (2016-2027)
6.2 North America Rheumatoid Arthritis Devices Market Size by Application
6.2.1 North America Rheumatoid Arthritis Devices Sales by Application (2016-2027)
6.2.2 North America Rheumatoid Arthritis Devices Revenue by Application (2016-2027)
6.3 North America Rheumatoid Arthritis Devices Market Size by Country
6.3.1 North America Rheumatoid Arthritis Devices Sales by Country (2016-2027)
6.3.2 North America Rheumatoid Arthritis Devices Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Devices Market Size by Type
7.1.1 Europe Rheumatoid Arthritis Devices Sales by Type (2016-2027)
7.1.2 Europe Rheumatoid Arthritis Devices Revenue by Type (2016-2027)
7.2 Europe Rheumatoid Arthritis Devices Market Size by Application
7.2.1 Europe Rheumatoid Arthritis Devices Sales by Application (2016-2027)
7.2.2 Europe Rheumatoid Arthritis Devices Revenue by Application (2016-2027)
7.3 Europe Rheumatoid Arthritis Devices Market Size by Country
7.3.1 Europe Rheumatoid Arthritis Devices Sales by Country (2016-2027)
7.3.2 Europe Rheumatoid Arthritis Devices Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rheumatoid Arthritis Devices Market Size by Type
8.1.1 Asia Pacific Rheumatoid Arthritis Devices Sales by Type (2016-2027)
8.1.2 Asia Pacific Rheumatoid Arthritis Devices Revenue by Type (2016-2027)
8.2 Asia Pacific Rheumatoid Arthritis Devices Market Size by Application
8.2.1 Asia Pacific Rheumatoid Arthritis Devices Sales by Application (2016-2027)
8.2.2 Asia Pacific Rheumatoid Arthritis Devices Revenue by Application (2016-2027)
8.3 Asia Pacific Rheumatoid Arthritis Devices Market Size by Region
8.3.1 Asia Pacific Rheumatoid Arthritis Devices Sales by Region (2016-2027)
8.3.2 Asia Pacific Rheumatoid Arthritis Devices Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Rheumatoid Arthritis Devices Market Size by Type
9.1.1 Latin America Rheumatoid Arthritis Devices Sales by Type (2016-2027)
9.1.2 Latin America Rheumatoid Arthritis Devices Revenue by Type (2016-2027)
9.2 Latin America Rheumatoid Arthritis Devices Market Size by Application
9.2.1 Latin America Rheumatoid Arthritis Devices Sales by Application (2016-2027)
9.2.2 Latin America Rheumatoid Arthritis Devices Revenue by Application (2016-2027)
9.3 Latin America Rheumatoid Arthritis Devices Market Size by Country
9.3.1 Latin America Rheumatoid Arthritis Devices Sales by Country (2016-2027)
9.3.2 Latin America Rheumatoid Arthritis Devices Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rheumatoid Arthritis Devices Market Size by Type
10.1.1 Middle East and Africa Rheumatoid Arthritis Devices Sales by Type (2016-2027)
10.1.2 Middle East and Africa Rheumatoid Arthritis Devices Revenue by Type (2016-2027)
10.2 Middle East and Africa Rheumatoid Arthritis Devices Market Size by Application
10.2.1 Middle East and Africa Rheumatoid Arthritis Devices Sales by Application (2016-2027)
10.2.2 Middle East and Africa Rheumatoid Arthritis Devices Revenue by Application (2016-2027)
10.3 Middle East and Africa Rheumatoid Arthritis Devices Market Size by Country
10.3.1 Middle East and Africa Rheumatoid Arthritis Devices Sales by Country (2016-2027)
10.3.2 Middle East and Africa Rheumatoid Arthritis Devices Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Active Implants LLC
11.1.1 Active Implants LLC Corporation Information
11.1.2 Active Implants LLC Overview
11.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Active Implants LLC Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Active Implants LLC Recent Developments
11.2 Anika Therapeutics, Inc.
11.2.1 Anika Therapeutics, Inc. Corporation Information
11.2.2 Anika Therapeutics, Inc. Overview
11.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Anika Therapeutics, Inc. Recent Developments
11.3 Arthrex, Inc.
11.3.1 Arthrex, Inc. Corporation Information
11.3.2 Arthrex, Inc. Overview
11.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Arthrex, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Arthrex, Inc. Recent Developments
11.4 Asahi Kasei Pharma Corporation
11.4.1 Asahi Kasei Pharma Corporation Corporation Information
11.4.2 Asahi Kasei Pharma Corporation Overview
11.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Asahi Kasei Pharma Corporation Recent Developments
11.5 B. Braun Melsungen AG
11.5.1 B. Braun Melsungen AG Corporation Information
11.5.2 B. Braun Melsungen AG Overview
11.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Melsungen AG Recent Developments
11.6 CONMED Corporation
11.6.1 CONMED Corporation Corporation Information
11.6.2 CONMED Corporation Overview
11.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 CONMED Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CONMED Corporation Recent Developments
11.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
11.7.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Corporation Information
11.7.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Overview
11.7.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments
11.8 Integra Lifesciences Corporation
11.8.1 Integra Lifesciences Corporation Corporation Information
11.8.2 Integra Lifesciences Corporation Overview
11.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Integra Lifesciences Corporation Recent Developments
11.9 Johnson & Johnson (DePuy Synthes Inc.)
11.9.1 Johnson & Johnson (DePuy Synthes Inc.) Corporation Information
11.9.2 Johnson & Johnson (DePuy Synthes Inc.) Overview
11.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson & Johnson (DePuy Synthes Inc.) Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Overview
11.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Novartis AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis AG Recent Developments
11.11 RTI Surgical, Inc.
11.11.1 RTI Surgical, Inc. Corporation Information
11.11.2 RTI Surgical, Inc. Overview
11.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 RTI Surgical, Inc. Recent Developments
11.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
11.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Corporation Information
11.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Overview
11.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments
11.13 Setpoint Medical Corporation
11.13.1 Setpoint Medical Corporation Corporation Information
11.13.2 Setpoint Medical Corporation Overview
11.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Setpoint Medical Corporation Recent Developments
11.14 Smith & Nephew plc (Osiris Therapeutics, Inc.)
11.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Corporation Information
11.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Overview
11.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Developments
11.15 Stryker Corporation (OrthoSpace Ltd.)
11.15.1 Stryker Corporation (OrthoSpace Ltd.) Corporation Information
11.15.2 Stryker Corporation (OrthoSpace Ltd.) Overview
11.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Stryker Corporation (OrthoSpace Ltd.) Recent Developments
11.16 UCB Pharma S.A.
11.16.1 UCB Pharma S.A. Corporation Information
11.16.2 UCB Pharma S.A. Overview
11.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 UCB Pharma S.A. Recent Developments
11.17 Zimmer Biomet
11.17.1 Zimmer Biomet Corporation Information
11.17.2 Zimmer Biomet Overview
11.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Zimmer Biomet Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Zimmer Biomet Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Rheumatoid Arthritis Devices Value Chain Analysis
12.2 Rheumatoid Arthritis Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rheumatoid Arthritis Devices Production Mode & Process
12.4 Rheumatoid Arthritis Devices Sales and Marketing
12.4.1 Rheumatoid Arthritis Devices Sales Channels
12.4.2 Rheumatoid Arthritis Devices Distributors
12.5 Rheumatoid Arthritis Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rheumatoid Arthritis Devices Industry Trends
13.2 Rheumatoid Arthritis Devices Market Drivers
13.3 Rheumatoid Arthritis Devices Market Challenges
13.4 Rheumatoid Arthritis Devices Market Restraints
14 Key Findings in The Global Rheumatoid Arthritis Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Rheumatoid Arthritis Devices Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Implantable Joint Prostheses
Table 3. Major Manufacturers of Spinal Devices
Table 4. Major Manufacturers of Other
Table 5. Global Rheumatoid Arthritis Devices Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Rheumatoid Arthritis Devices Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Rheumatoid Arthritis Devices Sales by Region (2016-2021) & (K Units)
Table 8. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2016-2021)
Table 9. Global Rheumatoid Arthritis Devices Sales by Region (2022-2027) & (K Units)
Table 10. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2022-2027)
Table 11. Global Rheumatoid Arthritis Devices Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Rheumatoid Arthritis Devices Revenue Market Share by Region (2016-2021)
Table 13. Global Rheumatoid Arthritis Devices Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Rheumatoid Arthritis Devices Revenue Market Share by Region (2022-2027)
Table 15. Global Rheumatoid Arthritis Devices Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Rheumatoid Arthritis Devices Sales Share by Manufacturers (2016-2021)
Table 17. Global Rheumatoid Arthritis Devices Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Rheumatoid Arthritis Devices Revenue Share by Manufacturers (2016-2021)
Table 19. Rheumatoid Arthritis Devices Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Rheumatoid Arthritis Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Rheumatoid Arthritis Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Devices as of 2020)
Table 22. Rheumatoid Arthritis Devices Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Rheumatoid Arthritis Devices Product Offered
Table 24. Date of Manufacturers Enter into Rheumatoid Arthritis Devices Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 27. Global Rheumatoid Arthritis Devices Sales by Type (2022-2027) & (K Units)
Table 28. Global Rheumatoid Arthritis Devices Sales Share by Type (2016-2021)
Table 29. Global Rheumatoid Arthritis Devices Sales Share by Type (2022-2027)
Table 30. Global Rheumatoid Arthritis Devices Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Rheumatoid Arthritis Devices Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Rheumatoid Arthritis Devices Revenue Share by Type (2016-2021)
Table 33. Global Rheumatoid Arthritis Devices Revenue Share by Type (2022-2027)
Table 34. Rheumatoid Arthritis Devices Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Rheumatoid Arthritis Devices Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 37. Global Rheumatoid Arthritis Devices Sales by Application (2022-2027) & (K Units)
Table 38. Global Rheumatoid Arthritis Devices Sales Share by Application (2016-2021)
Table 39. Global Rheumatoid Arthritis Devices Sales Share by Application (2022-2027)
Table 40. Global Rheumatoid Arthritis Devices Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Rheumatoid Arthritis Devices Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Rheumatoid Arthritis Devices Revenue Share by Application (2016-2021)
Table 43. Global Rheumatoid Arthritis Devices Revenue Share by Application (2022-2027)
Table 44. Rheumatoid Arthritis Devices Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Rheumatoid Arthritis Devices Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 47. North America Rheumatoid Arthritis Devices Sales by Type (2022-2027) & (K Units)
Table 48. North America Rheumatoid Arthritis Devices Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Rheumatoid Arthritis Devices Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 51. North America Rheumatoid Arthritis Devices Sales by Application (2022-2027) & (K Units)
Table 52. North America Rheumatoid Arthritis Devices Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Rheumatoid Arthritis Devices Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units)
Table 55. North America Rheumatoid Arthritis Devices Sales by Country (2022-2027) & (K Units)
Table 56. North America Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Rheumatoid Arthritis Devices Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 59. Europe Rheumatoid Arthritis Devices Sales by Type (2022-2027) & (K Units)
Table 60. Europe Rheumatoid Arthritis Devices Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Rheumatoid Arthritis Devices Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 63. Europe Rheumatoid Arthritis Devices Sales by Application (2022-2027) & (K Units)
Table 64. Europe Rheumatoid Arthritis Devices Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Rheumatoid Arthritis Devices Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units)
Table 67. Europe Rheumatoid Arthritis Devices Sales by Country (2022-2027) & (K Units)
Table 68. Europe Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Rheumatoid Arthritis Devices Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Rheumatoid Arthritis Devices Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Rheumatoid Arthritis Devices Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Rheumatoid Arthritis Devices Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Rheumatoid Arthritis Devices Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Rheumatoid Arthritis Devices Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Rheumatoid Arthritis Devices Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Rheumatoid Arthritis Devices Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Rheumatoid Arthritis Devices Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Rheumatoid Arthritis Devices Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Rheumatoid Arthritis Devices Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Rheumatoid Arthritis Devices Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Rheumatoid Arthritis Devices Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Rheumatoid Arthritis Devices Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Rheumatoid Arthritis Devices Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Rheumatoid Arthritis Devices Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Rheumatoid Arthritis Devices Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Rheumatoid Arthritis Devices Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Rheumatoid Arthritis Devices Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Rheumatoid Arthritis Devices Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Rheumatoid Arthritis Devices Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Rheumatoid Arthritis Devices Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Rheumatoid Arthritis Devices Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Rheumatoid Arthritis Devices Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Country (2022-2027) & (US$ Million)
Table 106. Active Implants LLC Corporation Information
Table 107. Active Implants LLC Description and Major Businesses
Table 108. Active Implants LLC Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Active Implants LLC Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Active Implants LLC Recent Developments
Table 111. Anika Therapeutics, Inc. Corporation Information
Table 112. Anika Therapeutics, Inc. Description and Major Businesses
Table 113. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Anika Therapeutics, Inc. Recent Developments
Table 116. Arthrex, Inc. Corporation Information
Table 117. Arthrex, Inc. Description and Major Businesses
Table 118. Arthrex, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Arthrex, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Arthrex, Inc. Recent Developments
Table 121. Asahi Kasei Pharma Corporation Corporation Information
Table 122. Asahi Kasei Pharma Corporation Description and Major Businesses
Table 123. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Asahi Kasei Pharma Corporation Recent Developments
Table 126. B. Braun Melsungen AG Corporation Information
Table 127. B. Braun Melsungen AG Description and Major Businesses
Table 128. B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. B. Braun Melsungen AG Recent Developments
Table 131. CONMED Corporation Corporation Information
Table 132. CONMED Corporation Description and Major Businesses
Table 133. CONMED Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. CONMED Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. CONMED Corporation Recent Developments
Table 136. EMulate Therapeutics, Inc. (Nativis, Inc.) Corporation Information
Table 137. EMulate Therapeutics, Inc. (Nativis, Inc.) Description and Major Businesses
Table 138. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments
Table 141. Integra Lifesciences Corporation Corporation Information
Table 142. Integra Lifesciences Corporation Description and Major Businesses
Table 143. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Integra Lifesciences Corporation Recent Developments
Table 146. Johnson & Johnson (DePuy Synthes Inc.) Corporation Information
Table 147. Johnson & Johnson (DePuy Synthes Inc.) Description and Major Businesses
Table 148. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Johnson & Johnson (DePuy Synthes Inc.) Recent Developments
Table 151. Novartis AG Corporation Information
Table 152. Novartis AG Description and Major Businesses
Table 153. Novartis AG Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 154. Novartis AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Novartis AG Recent Developments
Table 156. RTI Surgical, Inc. Corporation Information
Table 157. RTI Surgical, Inc. Description and Major Businesses
Table 158. RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 159. RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. RTI Surgical, Inc. Recent Developments
Table 161. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Corporation Information
Table 162. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Description and Major Businesses
Table 163. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 164. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments
Table 166. Setpoint Medical Corporation Corporation Information
Table 167. Setpoint Medical Corporation Description and Major Businesses
Table 168. Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 169. Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Setpoint Medical Corporation Recent Developments
Table 171. Smith & Nephew plc (Osiris Therapeutics, Inc.) Corporation Information
Table 172. Smith & Nephew plc (Osiris Therapeutics, Inc.) Description and Major Businesses
Table 173. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 174. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Developments
Table 176. Stryker Corporation (OrthoSpace Ltd.) Corporation Information
Table 177. Stryker Corporation (OrthoSpace Ltd.) Description and Major Businesses
Table 178. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 179. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Stryker Corporation (OrthoSpace Ltd.) Recent Developments
Table 181. UCB Pharma S.A. Corporation Information
Table 182. UCB Pharma S.A. Description and Major Businesses
Table 183. UCB Pharma S.A. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 184. UCB Pharma S.A. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. UCB Pharma S.A. Recent Developments
Table 186. Zimmer Biomet Corporation Information
Table 187. Zimmer Biomet Description and Major Businesses
Table 188. Zimmer Biomet Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 189. Zimmer Biomet Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 190. Zimmer Biomet Recent Developments
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. Rheumatoid Arthritis Devices Distributors List
Table 194. Rheumatoid Arthritis Devices Customers List
Table 195. Rheumatoid Arthritis Devices Market Trends
Table 196. Rheumatoid Arthritis Devices Market Drivers
Table 197. Rheumatoid Arthritis Devices Market Challenges
Table 198. Rheumatoid Arthritis Devices Market Restraints
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Rheumatoid Arthritis Devices Product Picture
Figure 3. Global Rheumatoid Arthritis Devices Market Share by Type in 2020 & 2027
Figure 3. Implantable Joint Prostheses Product Picture
Figure 4. Spinal Devices Product Picture
Figure 5. Other Product Picture
Figure 6. Global Rheumatoid Arthritis Devices Market Share by Application in 2020 & 2027
Figure 7. Elderly
Figure 8. Young adults
Figure 9. Rheumatoid Arthritis Devices Report Years Considered
Figure 10. Global Rheumatoid Arthritis Devices Sales 2016-2027 (K Units)
Figure 11. Global Rheumatoid Arthritis Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Rheumatoid Arthritis Devices Revenue 2016-2027 (US$ Million)
Figure 13. Global Rheumatoid Arthritis Devices Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2016-2021)
Figure 15. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2022-2027)
Figure 16. North America Rheumatoid Arthritis Devices Sales YoY (2016-2027) & (K Units)
Figure 17. North America Rheumatoid Arthritis Devices Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Rheumatoid Arthritis Devices Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Rheumatoid Arthritis Devices Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Rheumatoid Arthritis Devices Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Rheumatoid Arthritis Devices Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Rheumatoid Arthritis Devices Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Rheumatoid Arthritis Devices Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Rheumatoid Arthritis Devices Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Rheumatoid Arthritis Devices Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Rheumatoid Arthritis Devices Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Rheumatoid Arthritis Devices Revenue in 2020
Figure 28. Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2027)
Figure 30. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2027)
Figure 31. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2027)
Figure 32. Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2016-2027)
Figure 33. North America Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2027)
Figure 34. North America Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2027)
Figure 35. North America Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2027)
Figure 36. North America Rheumatoid Arthritis Devices Revenue Market Share by Application (2016-2027)
Figure 37. North America Rheumatoid Arthritis Devices Sales Share by Country (2016-2027)
Figure 38. North America Rheumatoid Arthritis Devices Revenue Share by Country (2016-2027)
Figure 39. United States Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2027)
Figure 42. Europe Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2027)
Figure 43. Europe Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2027)
Figure 44. Europe Rheumatoid Arthritis Devices Revenue Market Share by Application (2016-2027)
Figure 45. Europe Rheumatoid Arthritis Devices Sales Share by Country (2016-2027)
Figure 46. Europe Rheumatoid Arthritis Devices Revenue Share by Country (2016-2027)
Figure 47. Germany Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 48. France Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Rheumatoid Arthritis Devices Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Rheumatoid Arthritis Devices Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Rheumatoid Arthritis Devices Revenue Share by Region (2016-2027)
Figure 58. China Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 61. India Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2027)
Figure 68. Latin America Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2027)
Figure 70. Latin America Rheumatoid Arthritis Devices Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Rheumatoid Arthritis Devices Sales Share by Country (2016-2027)
Figure 72. Latin America Rheumatoid Arthritis Devices Revenue Share by Country (2016-2027)
Figure 73. Mexico Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Rheumatoid Arthritis Devices Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Rheumatoid Arthritis Devices Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Rheumatoid Arthritis Devices Revenue Share by Country (2016-2027)
Figure 82. Turkey Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Rheumatoid Arthritis Devices Revenue (2016-2027) & (US$ Million)
Figure 85. Rheumatoid Arthritis Devices Value Chain
Figure 86. Rheumatoid Arthritis Devices Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
脳磁図（MEG）装置のグローバル市場インサイト・予測（～2027年） Magnetoencphalography is a non-invasive medical test that uses a superconducting quantum interference device (SQUID) and a computer to measure neuromagnetic activity within the brain. MEG detects, records and analyzes the magnetic fields produced by electrical currents in the brain. Market Analysis …- OSA治療装置のグローバル市場インサイト・予測（～2027年） OSA Therapy Devices Market Analysis and Insights: Global OSA Therapy Devices Market The global OSA Therapy Devices market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global OSA Therapy Devices Scope and…
- 使い捨て呼吸装置のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Single-use Respiratory Devices Market The global Single-use Respiratory Devices market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Single-use Respiratory Devices Scop…
- 空間分割多重（SDM）デバイスのグローバル市場インサイト・予測（～2027年） Space Division Multiplexing (SDM) Devices can work with various kinds of fibers, including multi-core fibers and few-mode fibers. Components required for SDM include various kinds of fibers, spatial multiplexers, adapted fiber amplifiers Market Analysis and Insights: Global Space Division Multiplexi…
- 末梢介入装置のグローバル市場インサイト・予測（～2027年） Peripheral Interventional Devices Market Analysis and Insights: Global Peripheral Interventional Devices Market The global Peripheral Interventional Devices market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-…